Pear Therapeutics received market authorization from the FDA for its insomnia digital therapeutic, Somryst. It is Pear’s third product to receive FDA clearance, and the first product to be ...

As Pear Therapeutics’ financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on the road for digital therapeutics, or a sign of darker ...

Pear Therapeutics is also working on an opioid version of the cognitive behavioural therapy app, named reSET-O, for which it hopes to gain FDA approval for patients with opioid use disorder who ...

PEARL RIVER - Acorda Therapeutics, which manufactures key medications used by MS and Parkinson's patients, will lay off all its 97 employees in June, according to a notice filed with the New York ...